Moreover, colchicine did not influence NAFLD activity score but significantly increased ALT and AST levels, suggesting that colchicine amplified the hepatocellular injury produced by the diet. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.